Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis-Reference-Cited by-同舟云学术

Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis

Published:2019-04 Issue:4 Volume:22 Page:453-466
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Hudgens Stacie,Schüler René,Stokes Jonathan,Eremenco Sonya,Hunsche Elke,Leist Thomas P.

Funder

Actelion Pharmaceuticals Ltd

Adelphi

Actelion

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference43 articles.

1. Longitudinal correlates of fatigue in multiple sclerosis;Patrick;Mult Scler,2009

2. The impact of fatigue on patients with multiple sclerosis;Fisk;Can J Neurol Sci,1994

3. Symptoms and association with health outcomes in relapsing-remitting multiple sclerosis: results of a US patient survey;Williams;Mult Scler Int,2014

4. Immunopathology of multiple sclerosis;Dendrou;Nat Rev Immunol,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic literature review of the measurement of patient-reported fatigue in studies of disease modifying therapies for multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-11

2. Meaningful Change Thresholds and Fatigue Severity Points on Patient-Reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire in Patients With Relapsing Multiple Sclerosis;Value in Health;2024-05

3. Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS;BMC Neurology;2024-04-25

4. Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study;Journal of Women's Health;2024-04-01

5. Understanding the Symptoms and Impacts Experienced by People with Relapsing–Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews;Neurology and Therapy;2024-02-12